RxDoctor Payments Data

Harlyn Naika Veloso

Family · Las Vegas, NVNPI 1740921667

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (56.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 48.3% of the total. Among family clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,353in general payments, 2019–2025

Across 124 payments — averaging $91.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Boston Scientific$2K
  • Spinal Simplicity, LLC$1K
  • Curonix LLC$1K
  • Lundbeck LLC$478
  • AbbVie$311
  • plus $532 from 6 others

What the payments were for

  • Travel & lodging$6,40456%
  • Food & beverage$4,80442%
  • Education$1441%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,353 in reported general payments places this provider in the 95th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada

Medicare billing

Part B allowed, 2024
$141,463
Medicare patients
234
Services billed
1,775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen312$23,821
Xtampza ErOxycodone Myristate22$10,508
OxycontinOxycodone Hcl16$6,809
Oxycodone Hcl235$5,504
Hydrocodone Bitartrate ErHydrocodone Bitartrate14$4,967
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen211$4,709
Lidocaine24$4,456
Naloxone Hcl44$3,042
Fentanyl26$2,262
Morphine Sulfate ErMorphine Sulfate113$2,226
Gabapentin182$2,089
Pregabalin84$1,543
Ondansetron OdtOndansetron26$1,393
Tramadol Hcl53$1,198
Cyclobenzaprine Hcl93$654

Paid to pharmacies, not to this prescriber.

Other family in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →